(Total Views: 506)
Posted On: 06/02/2019 2:21:18 PM
Post# of 154969
Re: ClosetInvestor #3709
CCR5 is expressed in over 50% of all breast cancers.
Dr Pestell pick of TNBC for our studies is because about 97% of those patients expressing CCR5 , and cancer is very deadly .
But when approved , it will be given to any other breast cancer when cancer cells will be CCR5 positive.
And it will be used with other medicine , it is not a competition with them , but it will be use together for those patients....
Dr Pestell pick of TNBC for our studies is because about 97% of those patients expressing CCR5 , and cancer is very deadly .
But when approved , it will be given to any other breast cancer when cancer cells will be CCR5 positive.
And it will be used with other medicine , it is not a competition with them , but it will be use together for those patients....
(0)
(0)
